DNA ploidy and p53 protein expression in superficial transitional cell carcinoma of the bladder

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cytopathology

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2303.2000.00225.xPMID 10772009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer

  2004cited by this paper
• Immunohistochemical determination of p53 overexpression

  2004cited by this paper
• Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma

  2004cited by this paper
• Bladder cancer.

  1998cited by this paper
• P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer.

  1997cited by this paper
• Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.

  1997cited by this paper
• DNA content and p53 protein expression in ductal breast cancer

  1997cited by this paper
• Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.

  1997cited by this paper
• DNA ploidy and pS2 protein expression in breast cancer

  1997cited by this paper
• DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.

  1997cited by this paper
• P53 protein expression and DNA ploidy in common epithelial tumors of the ovary.

  1997cited by this paper
• Prevalence and Clinical Significance of Her-2/neu, p53 and Rb Expression in Primary Superficial Bladder Cancer

  1996cited by this paper
• Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder

  1996cited by this paper
• Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancer.

  1996cited by this paper
• Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.

  1995cited by this paper
• The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.

  1995cited by this paper
• p53 immunocytochemical staining in diagnostic cytopathology: the relevance of the proportion of positive cells

  1995cited by this paper
• Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.

  1995cited by this paper
• p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.

  1995cited by this paper
• p53 protein expression in fine‐needle aspirates of breast cancer: An immunocytochemical assay for identifying high‐grade ductal carcinomas

  1995cited by this paper
• Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.

  1995cited by this paper
• Expression of proliferating cell nuclear antigen, Ki‐67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: An immunochemical study with clinical, pathobiological, and histologic correlations

  1994cited by this paper
• Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breast

  1994cited by this paper
• Image cytometric DNA analysis in transitional cell carcinoma of the bladder

  1993cited by this paper
• p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

  1993cited by this paper
• Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer.

  1993cited by this paper
• Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference.

  1993cited by this paper
• Over‐expression of p53 nuclear oncoprotein in transitional‐cell bladder cancer and its prognostic value

  1993cited by this paper
• Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

  1993cited by this paper
• High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA Aneuploidy

  1992cited by this paper
• The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy.

  1992cited by this paper
• Managing superficial bladder cancer: an overview.

  1992cited by this paper
• [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].

  1992cited by this paper
• Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder.

  1992cited by this paper
• An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

  1992cited by this paper
• Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients.

  1991cited by this paper
• Biology and management of bladder cancer.

  1990cited by this paper
• The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer.

  1988cited by this paper
• Biological behaviour and DNA cytophotometry of urothelial bladder carcinoma.

  1984cited by this paper
• DNA profile and tumour progression in patients with superfical bladder tumours

  1982cited by this paper

• Molecular Markers in Upper Urothelial Carcinoma Associated to Balkan Endemic Nephropathy. Aristolochic Acid as the Major Risk Factor of the Worldwide Disease

  2009cites this paper
• DNA image cytometry in bladder cancer: state of the art.

  2008cites this paper
• Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.

  2006cites this paper
• P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

  2005cites this paper
• DNA ploidy and immunomarking of bladder urothelial tumors before and after intravesical bacillus Calmette-Guérin treatment.

  2005cites this paper
• Image analysis (DNA ploidy) and expression of c-erb B-2 and p53 in imprint smears of breast cancer.

  2003cites this paper
• DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma.

  2002cites this paper
• Intermediate biomarkers.

  2001cites this paper
• Author index to Volume 11

  2000cites this paper